PriceTargets.com logo

cbdMD - YCBD Stock Price Target and Predictions

  • Consensus Rating: N/A
  • Consensus Price Target: $0.00
  • Forecasted Upside: -100.00%
  • Number of Analysts: 0
  • Breakdown:
  • 0 Sell Ratings
  • 0 Hold Ratings
  • 0 Buy Ratings
  • 0 Strong Buy Ratings
$0.20 As of 03/30/2023 01:00 AM ET
▲ +0.02 (11.36%)

This chart shows the closing price for YCBD by one month, three months, or twelve months.

Skip Closing Price Chart
1 month | 3 months | 12 months
Get New cbdMD Analyst Ratings Delivered To Your Inbox
Sign-up to receive the latest news and ratings for YCBD and its competitors with Analyst Ratings Network’s free daily newsletter.

Analyst Price Target for YCBD

Analyst Price Target is $0.00
▼ -100.00% Downside Potential
This price target is based on 0 analysts offering 12 month price targets for cbdMD in the last 3 months. The average price target is $0.00, with a high forecast of $0.00 and a low forecast of $10,000,000.00. The average price target represents a -100.00% upside from the last price of $0.20.

This chart shows the closing price for YCBD for the last year in relation to the current analyst high, average, and low pricetarget.

Read Analyst Price Chart DescriptionSkip Analyst Price Chart

Current Consensus is N/A

The current consensus among 0 contributing investment analysts is to n/a stock in cbdMD. This rating has held steady since June 2022, when it changed from a Hold consensus rating.

Past Monthly Recommendations

Move your mouse over past months for details

Read Past Recommendations DescriptionSkip Past Price Target Consensus Chart
  • 0 strong buy ratings
  • 0 buy ratings
  • 1 hold ratings
  • 0 sell ratings
Ratings as of
10/6/2021
  • 0 strong buy ratings
  • 0 buy ratings
  • 1 hold ratings
  • 0 sell ratings
Ratings as of
1/4/2022
  • 0 strong buy ratings
  • 0 buy ratings
  • 1 hold ratings
  • 0 sell ratings
Ratings as of
4/4/2022
  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 0 sell ratings
Ratings as of
7/3/2022
  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 0 sell ratings
Ratings as of
10/1/2022
  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 0 sell ratings
Ratings as of
12/30/2022
  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 0 sell ratings
Ratings as of
2/28/2023
  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 0 sell ratings
Ratings as of
3/30/2023

Latest Recommendations

  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 0 sell ratings

Display Ratings By
DateBrokerageActionRatingPrice TargetDetails
6/18/2021Cantor FitzgeraldReiterated RatingNeutral$4.10 ➝ $3.25
1/29/2021Cantor FitzgeraldBoost TargetNeutral$3.60 ➝ $4.30
12/8/2020Cantor FitzgeraldReiterated RatingNeutral
9/9/2020BenchmarkBoost TargetSpeculative Buy$3.00 ➝ $4.00
8/13/2020Cantor FitzgeraldBoost TargetNeutral$1.80 ➝ $3.60
5/18/2020Cantor FitzgeraldBoost TargetNeutral$1.20 ➝ $1.80
3/9/2020Cantor FitzgeraldBoost TargetNeutral$1.20 ➝ $3.40
12/19/2019BenchmarkLower TargetSpeculative Buy$9.00 ➝ $7.00
11/8/2019Cantor FitzgeraldReiterated RatingNeutral
11/7/2019Cantor FitzgeraldInitiated CoverageNeutral
9/10/2019BenchmarkInitiated CoverageBuy$9.00
(Data available from 3/30/2018 forward)

News Sentiment Rating

Our news sentiment rating is based on the average sentiment of articles about this company published in the media in the last 30 days of headlines and can range from 2 (very positive sentiment) to -2 (very negative sentiment).

News Sentiment Over Time

Move your mouse over past months for details

Skip to Current Sentiment Summary
  • 3 very positive mentions
  • 4 positive mentions
  • 1 negative mentions
  • 0 very negative mentions
Mentions as of
9/1/2022
  • 3 very positive mentions
  • 2 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
Mentions as of
10/1/2022
  • 3 very positive mentions
  • 0 positive mentions
  • 1 negative mentions
  • 1 very negative mentions
Mentions as of
10/31/2022
  • 2 very positive mentions
  • 0 positive mentions
  • 1 negative mentions
  • 0 very negative mentions
Mentions as of
11/30/2022
  • 2 very positive mentions
  • 0 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
Mentions as of
12/30/2022
  • 2 very positive mentions
  • 1 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
Mentions as of
1/29/2023
  • 3 very positive mentions
  • 1 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
Mentions as of
2/28/2023
  • 0 very positive mentions
  • 0 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
Mentions as of
3/30/2023

Current Sentiment

  • 0 very positive mentions
  • 0 positive mentions
  • 0 negative mentions
  • 0 very negative mentions

Recent Stories by Sentiment

Very Negative

  • No very negative mentions tracked during this time.

Negative

  • No negative mentions tracked during this time.

Positive

  • No positive mentions tracked during this time.

Very Positive

  • No very positive mentions tracked during this time.
cbdMD logo
cbdMD, Inc. engages in the business of operating cannabidiol brands such as Paw cannabidiol and cbdMD botanicals. Its product categories include CBD tinctures, gummies, topical, and bath bombs. The company was founded by Caryn Dunayer on March 17, 2015 and is headquartered in Charlotte, NC.
Read More

Today's Range

Now: $0.20
Low: $0.18
High: $0.20

50 Day Range

MA: N/A

52 Week Range

Now: $0.20
Low: $0.16
High: $1.13

Volume

176,001 shs

Average Volume

219,984 shs

Market Capitalization

$12.82 million

P/E Ratio

N/A

Dividend Yield

N/A

Beta

2.14

Frequently Asked Questions

What sell-side analysts currently cover shares of cbdMD?

The following sell-side analysts have issued reports on cbdMD in the last twelve months:
View the latest analyst ratings for YCBD.

What is the current price target for cbdMD?

0 Wall Street analysts have set twelve-month price targets for cbdMD in the last year. has the lowest price target set, forecasting a price of $10,000,000.00 for cbdMD in the next year.
View the latest price targets for YCBD.

What is the current consensus analyst rating for cbdMD?

cbdMD currently has from Wall Street analysts. The stock has a consensus analyst rating of "N/A."
View the latest ratings for YCBD.

What other companies compete with cbdMD?

Other companies that are similar to cbdMD include FOXO Technologies, mCloud Technologies, Peraso, ZW Data Action Technologies and Smart Powerr. Learn More about companies similar to cbdMD.

How do I contact cbdMD's investor relations team?

cbdMD's physical mailing address is 8845 Red Oak Boulevard, Charlotte NC, 28217. The company's listed phone number is (704) 445-3060 and its investor relations email address is [email protected] The official website for cbdMD is www.cbdmd.com. Learn More about contacing cbdMD investor relations.